Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries



Status:Completed
Conditions:Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - 40
Updated:1/5/2019
Start Date:May 2013
End Date:October 22, 2018

Use our guide to learn which trials are right for you!

The purpose of this study is to determine if intrathecal hydromorphone will relieve pain as
well as intrathecal morphine after cesarean delivery, with fewer side effects.

Intrathecal morphine has long been the standard pain medication used in cesarean sections.
Since some patients cannot tolerate morphine, hydromorphone may be an acceptable alternative.
Intrathecal Intrathecal hydromorphone has been shown to be effective at treating post
cesarean section pain and possibly with less side effects than morphine.

One side effect of morphine is respiratory depression occurring hours after the start of
morphine use. Respiratory depression occurs when air being taken into the lungs is less than
normal, leading to a lower amount of oxygen and carbon dioxide being exchanged in the blood
stream. Because hydromorphone dosages are lower and it has a quicker onset of action than
morphine, it is believed that the use of hydromorphone should decrease the possibility of
delayed respiratory depression.

Inclusion Criteria:

- Scheduled for elective Cesarean sections under spinal anesthesia or combined spinal
anesthesia

- ASA status of I-III

- BMI < 40

- Able to understand and sign informed consent

Exclusion Criteria:

- Severe pre-eclampsia

- Conversion to general anesthetic

- History of chronic opioid use

- Allergy to morphine, or hydromorphone

- Hyperemesis gravidarum

- Emergency case

- Patients who have an infection at the intended site of spinal insertion
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials